Related Experiment Video

Updated: Dec 1, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Update 2020: Management of Non-Small Cell Lung Cancer

Mariam Alexander1, So Yeon Kim2, Haiying Cheng3

  • 1Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.

Lung
|November 11, 2020
PubMed

Insights

Recent advances in non-small cell lung cancer (NSCLC) management include improved screening, diagnosis, and targeted therapies. This review covers updates in screening, liquid biopsy, and front-line immunotherapy for NSCLC patients.

Area of Science:

  • Oncology
  • Pulmonology
  • Genetics

Background:

  • Non-small cell lung cancer (NSCLC) management has seen significant progress.
  • Systemic treatments have been revolutionized by targeted therapies, immunotherapies, and anti-angiogenic agents.
  • These advances have led to substantially improved patient outcomes.

Purpose of the Study:

  • To review recent updates in NSCLC screening and diagnosis.
  • To discuss advancements in front-line immunotherapy for NSCLC.
  • To highlight new molecular-targeted therapies for specific NSCLC patient subgroups.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Analysis of new drug approvals and treatment guidelines.
  • Focus on molecular profiling and targeted therapy selection.

Main Results:

  • Significant progress in early detection through enhanced screening methods.
  • Emergence of effective immune checkpoint inhibitors for first-line NSCLC treatment.
  • Numerous new targeted therapies approved for NSCLC with specific genetic alterations (EGFR, ALK, ROS1, RET, BRAF V600E, MET, NTRK).

Conclusions:

  • The landscape of NSCLC treatment has been transformed by precision medicine.
  • Personalized therapeutic strategies based on molecular profiling are crucial for optimal patient outcomes.
  • Continued research and development are essential for further improving NSCLC management.
Keywords:
Immune checkpoint inhibitorsLung cancerTargeted therapy

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

156
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
574
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K